HomeGDTC • NASDAQ
CytoMed Therapeutics Ltd
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (SGD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 139.59K | 24.91% |
Operating expense | 865.47K | -15.11% |
Net income | -714.15K | 27.67% |
Net profit margin | -511.59 | 42.10% |
Earnings per share | — | — |
EBITDA | -658.88K | 19.52% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (SGD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.97M | -44.74% |
Total assets | 10.07M | -18.60% |
Total liabilities | 1.02M | -8.96% |
Total equity | 9.04M | — |
Shares outstanding | 11.54M | — |
Price to book | 2.87 | — |
Return on assets | -18.38% | — |
Return on capital | -19.47% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (SGD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -714.15K | 27.67% |
Cash from operations | -777.03K | -3.78% |
Cash from investing | 1.51M | 10.45% |
Cash from financing | -17.68K | -6,777.43% |
Net change in cash | 736.98K | 19.91% |
Free cash flow | -673.88K | -34.38% |
Previous close
$2.24
Day range
$2.19 - $2.38
Year range
$1.20 - $4.05
Market cap
25.75M USD
Avg Volume
22.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2018
Website
Employees
43
